It has been 3 years since EuroPCR 2016 and the presentation of the first data on possible transcatheter valve degeneration, which sparked fear regarding the possibility that transcatherter aortic valve replacement (TAVR) devices might degrade earlier than expected due to the pressure put on them to introduce them into the delivery catheter. At EuroPCR 2019,...
SOLACI’s Interventional Women in Latin American Group (Grupo de Mujeres Intervencionistas en Latinoamérica, Grupo MIL), led by its Director, Carla Agatiello, will participate in a Think Tank organized by Women as One, next Saturday, May 25th, at Westin Paris Vendôme Hotel in France. The aim of this meeting is to foster and facilitate the inclusion...
Staged complete revascularization in patients with acute myocardial infarction and multivessel coronary disease is superior to culprit PCI only at five-year follow-up. The outcomes of this retrospective analysis show the benefit of staged PCI, though it might be attenuated in diabetic patients. Outcomes are consistent with previously published randomized studies. Nevertheless, we should remain cautious...
Once more, SOLACI is proud to participate at one of the most important interventional cardiology meetings in the world: the EuroPCR 2019. Together with our European sister institution, we will conduct an important joint session on “Innovations for the treatment of complex coronary artery lesions from LATAM”, where we will touch upon topics related to...
In the 2018 Guidelines on Hypertension, commandment no. 6 states that we should make lifestyle interventions such as sodium restriction, healthy eating, regular exercise, weight control, and smoking cessation, and also alcohol moderation. It is clear that heavy alcohol consumption induces hypertension and may probably be one of the main causes of secondary hypertension, but...
Courtesy of Dr. Carlos Fava. Mitral regurgitation (MR) is the most frequent valvulopathy in Europe and US, affecting close to 10% of patients over 75, with more morbidity and mortality. The treatment of choice is percutaneous repair instead of replacement, to maintain the sub-valvular apparatus that contributes to systole. This is feasible and has better...
Courtesy of Dr. Carlos Fava. Patients with low-flow low-gradient severe aortic stenosis are at higher risk, but there is a low-flow low-gradient group with preserved ejection fraction. These patients present systolic and diastolic ventricular dysfunction and their progress is different than that of the high-flow high-gradient normal ventricular function group. This study analyzed 1462 patients. Among them,...
Join us on May 15 thru 18 in Punta Cana, Dominican Republic, to celebrate the 27th Inter-American Congress and the 27th Dominican Congress of Cardiology, organized by the Inter-American Society of Cardiology (SIAC), where SOLACI will proudly hold a joint scientific session with the Inter-American Society of Cardiology (SIAC), the Dominican Society of Cardiology (SCD)...
After reports of some serious adverse events with first-generation Lotus, the device was pulled off the market—but it was not meant to be left in oblivion. Now, it is back, renewed and with the approval of the United States Food and Drug Administration (FDA), to compete directly with the two market leaders (Sapien and CoreValve),...
In-hospital PCI right after CABG is extremely rare, but it does increase morbidity, mortality and costs significantly. It is still unclear what predictors can be modified to prevent these very early angiography and angioplasty procedures in patients that generally leave the OR with visible EKG changes. Graft failure, distal vascular bed quality, technical error or...